| Product Code: ETC417504 | Publication Date: Oct 2022 | Updated Date: Jan 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In the Indonesia corticosteroids market, the import trend experienced a decline from 2023 to 2024, with a growth rate of -2.57%. The compound annual growth rate (CAGR) for imports between 2020 and 2024 stood at -20.73%. This downward trajectory may be attributed to shifts in demand dynamics or regulatory changes impacting import volumes.

Corticosteroids are widely used in Indonesia for their anti-inflammatory and immunosuppressive properties. The market for corticosteroids is influenced by the prevalence of inflammatory diseases and dermatological conditions. Ongoing research into the development of novel corticosteroid formulations, such as topical creams and ointments, is driving innovation in this sector. However, strict regulations on the use and distribution of corticosteroids require market participants to navigate complex compliance issues.
The Indonesia Corticosteroids market is experiencing steady growth due to several key drivers. First, the rising prevalence of inflammatory and autoimmune diseases, such as rheumatoid arthritis and asthma, has increased the demand for corticosteroid medications. Second, the aging population in Indonesia has led to a higher incidence of chronic conditions, further driving the need for corticosteroid treatments. Additionally, the expanding healthcare infrastructure and improved access to healthcare services have made these medications more accessible to the population. Lastly, increasing awareness among both healthcare professionals and patients about the benefits of corticosteroids in managing various medical conditions is positively impacting the market.
The Corticosteroids market may encounter challenges related to concerns about side effects, regulatory compliance, and competition from generic medications.
Corticosteroids saw increased use in COVID-19 treatments. The market experienced both demand surges and supply chain disruptions, impacting availability and pricing.
The Indonesia Corticosteroids market is expanding due to the rising cases of inflammatory and autoimmune disorders. Key players in this sector include PT. Dexa Medica, PT. Sanbe Farma, and PT. Kimia Farma.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Indonesia Corticosteroids Market Overview |
3.1 Indonesia Country Macro Economic Indicators |
3.2 Indonesia Corticosteroids Market Revenues & Volume, 2021 & 2031F |
3.3 Indonesia Corticosteroids Market - Industry Life Cycle |
3.4 Indonesia Corticosteroids Market - Porter's Five Forces |
3.5 Indonesia Corticosteroids Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Indonesia Corticosteroids Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Indonesia Corticosteroids Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of skin disorders and autoimmune diseases in Indonesia |
4.2.2 Growing awareness about the benefits of corticosteroids in treating various medical conditions |
4.2.3 Rising healthcare expenditure and improving healthcare infrastructure in the country |
4.3 Market Restraints |
4.3.1 Stringent regulations and guidelines regarding the use of corticosteroids in Indonesia |
4.3.2 Potential side effects and long-term complications associated with corticosteroid use |
4.3.3 Competition from alternative treatment options such as herbal medicines and traditional therapies |
5 Indonesia Corticosteroids Market Trends |
6 Indonesia Corticosteroids Market, By Types |
6.1 Indonesia Corticosteroids Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Indonesia Corticosteroids Market Revenues & Volume, By Application, 2021-2031F |
6.1.3 Indonesia Corticosteroids Market Revenues & Volume, By Skin Allergies, 2021-2031F |
6.1.4 Indonesia Corticosteroids Market Revenues & Volume, By Rhuematology Indications, 2021-2031F |
6.1.5 Indonesia Corticosteroids Market Revenues & Volume, By Endocrinology, 2021-2031F |
6.1.6 Indonesia Corticosteroids Market Revenues & Volume, By Acute Respiratory Diseases, 2021-2031F |
6.1.7 Indonesia Corticosteroids Market Revenues & Volume, By Others, 2021-2031F |
6.2 Indonesia Corticosteroids Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 Indonesia Corticosteroids Market Revenues & Volume, By Hospitals, 2021-2031F |
6.2.3 Indonesia Corticosteroids Market Revenues & Volume, By Clinics, 2021-2031F |
6.2.4 Indonesia Corticosteroids Market Revenues & Volume, By Research Institutes, 2021-2031F |
6.2.5 Indonesia Corticosteroids Market Revenues & Volume, By Others, 2021-2031F |
7 Indonesia Corticosteroids Market Import-Export Trade Statistics |
7.1 Indonesia Corticosteroids Market Export to Major Countries |
7.2 Indonesia Corticosteroids Market Imports from Major Countries |
8 Indonesia Corticosteroids Market Key Performance Indicators |
8.1 Number of dermatologist prescriptions for corticosteroids |
8.2 Patient adherence rate to corticosteroid treatment regimens |
8.3 Rate of new product launches and innovations in the corticosteroids market in Indonesia |
9 Indonesia Corticosteroids Market - Opportunity Assessment |
9.1 Indonesia Corticosteroids Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Indonesia Corticosteroids Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Indonesia Corticosteroids Market - Competitive Landscape |
10.1 Indonesia Corticosteroids Market Revenue Share, By Companies, 2024 |
10.2 Indonesia Corticosteroids Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here